Hypoxia-inducible factor-prolyl hydroxylase inhibitors in clinical practice: progress and considerations

Zhang Xiaoyan, Li Yang, Xiang Fangfang, Ding Xiaoqiang

PDF(617 KB)
Chinese Journal of Nephrology
Chinese Journal of Nephrology ›› 2025, Vol. 41 ›› Issue (12) : 1023-1028. DOI: 10.3760/cma.j.cn441217-20241227-01262
Review

Hypoxia-inducible factor-prolyl hydroxylase inhibitors in clinical practice: progress and considerations

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 41(12): 1023-1028. DOI: 10.3760/cma.j.cn441217-20241227-01262.

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(617 KB)

Accesses

Citation

Detail
Sections
Recommended

Copyright© by the Editorial Board of Chinese Journal of Nephrology, Chinese Medical Association and the First Affiliated Hospital of Sun Yat-sen University (Guangzhou) Journal Co., Ltd

Address: Floor 2, Longzhu building, No. 5, Zhusigang Second Road, Yuexiu District, Guangzhou (510080) Tel：(020)87331532　Email：cmaszb@mail.sysu.edu.cn

This system is designed and developed by Beijing magtec Technology Development Co., Ltd. with technical support: support@magtech.com.cn

粤ICP备10090623号

/

〈 〉